Therapeutic vaccine

We focus on immunotherapy for: 1. Cancers 2. Pre-cancer diseases 3. Infectious diseases Our company is led by accomplished BioPharma leaders, including Dr Frank L. Douglas, former Executive Vice President and Member of the Board of Management of Aventis, and Dr. Nahed Ahmed, former Senior Vice President in R and D in Aventis. We are a human therapeutic vaccine company belonging to Healthbanks Biotech Group. The Group comprises companies on stem cell banking/therapy, animal vaccine, and generic pharm. For additional information please contact us: 1. Data on TVGV-1 2. Licensing opportunities 3. Combinational therapywith TVGV-1 4. Formulation innovations 5. Possible partnership orcollaborations